19-39825750-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004714.3(DYRK1B):c.1855C>T(p.Arg619Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,561,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004714.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYRK1B | NM_004714.3 | c.1855C>T | p.Arg619Cys | missense_variant | 11/11 | ENST00000323039.10 | NP_004705.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYRK1B | ENST00000323039.10 | c.1855C>T | p.Arg619Cys | missense_variant | 11/11 | 1 | NM_004714.3 | ENSP00000312789.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152052Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000371 AC: 6AN: 161562Hom.: 0 AF XY: 0.0000228 AC XY: 2AN XY: 87550
GnomAD4 exome AF: 0.0000426 AC: 60AN: 1409474Hom.: 0 Cov.: 33 AF XY: 0.0000416 AC XY: 29AN XY: 696500
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152052Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74230
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | The c.1855C>T (p.R619C) alteration is located in exon 11 (coding exon 10) of the DYRK1B gene. This alteration results from a C to T substitution at nucleotide position 1855, causing the arginine (R) at amino acid position 619 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 22, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DYRK1B protein function. This variant has not been reported in the literature in individuals affected with DYRK1B-related conditions. This variant is present in population databases (rs778845035, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 619 of the DYRK1B protein (p.Arg619Cys). - |
DYRK1B-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 29, 2024 | The DYRK1B c.1855C>T variant is predicted to result in the amino acid substitution p.Arg619Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.025% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at